Literature DB >> 30359118

Factors affecting length of stay after percutaneous biliary interventions.

Mayank Roy1,2, Jimmy Kyaw Tun3, Abhirup Banerjee1,2, Shailesh Mohandas1, Ajit T Abraham1, Robert R Hutchins1, Satyajit Bhattacharya1, Ian Renfrew3, Deborah Low3, Tim Fotheringham3, Hemant M Kocher1,2.   

Abstract

OBJECTIVE: : To evaluate the factors affecting the length of hospital stay (LOS) after percutaneous transhepatic biliary drainage (PTBD).
METHODS: : A retrospective review of all patients who had undergone PTBD with or without stenting at a UK specialist centre between 2005 and 2016 was conducted.
RESULTS: : 692 patients underwent 1976 procedures over 731 clinical episodes for which, the median age was 65 (range 18-100) years, and the median Charlson Index was 3. PTBD was performed for malignant (n = 563) and benign strictures (n = 60), stones (n = 62), and bile leaks (n = 46). The median LOS was 13 (range 0-157) days, and the median interprocedure duration was 9 (range 0-304) days. The median number of procedures per patient was 2 and the median number of days required to complete a set of procedures for a patient (TBID) ranged from 0 to 557 days, with a median of 16 (interquartile range: 8-32) days. Patients with biliary leak had the highest LOS. Biliary stents were mostly placed at the second stage at a median of 6 (range 0-120) days from the first procedure day. Placement of a biliary stent in the first stage of the procedure was associated with shorter LOS (p < 0.001).
CONCLUSIONS: : Biliary stenting at index procedure reduces LOS, although it is not always technically possible. Patients with bile leak managed with PTBD have longer LOS. ADVANCES IN KNOWLEDGE:: This study provides data which can help in appropriate consenting, better planning, and efficient resource utilization for patients undergoing PTBD.

Entities:  

Mesh:

Year:  2019        PMID: 30359118      PMCID: PMC6540862          DOI: 10.1259/bjr.20180814

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  15 in total

1.  Percutaneous biliary metal wall stenting in malignant obstructive jaundice.

Authors:  Adrian A Indar; Dileep N Lobo; Andrew D Gilliam; Roger Gregson; Ian Davidson; Simon Whittaker; John Doran; Brian J Rowlands; Ian J Beckingham
Journal:  Eur J Gastroenterol Hepatol       Date:  2003-08       Impact factor: 2.566

2.  Endoscopic biliary drainage for severe acute cholangitis.

Authors:  E C Lai; F P Mok; E S Tan; C M Lo; S T Fan; K T You; J Wong
Journal:  N Engl J Med       Date:  1992-06-11       Impact factor: 91.245

3.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

Authors:  Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke
Journal:  Lancet       Date:  2007-10-20       Impact factor: 79.321

Review 4.  Palliative percutaneous drainage in malignant biliary obstruction. Part 2: Mechanisms and postprocedure management.

Authors:  Anne M Covey; Karen T Brown
Journal:  J Support Oncol       Date:  2006 Jul-Aug

5.  Prospective study of outcomes after percutaneous biliary drainage for malignant biliary obstruction.

Authors:  P C Robson; N Heffernan; M Gonen; R Thornton; L A Brody; R Holmes; K T Brown; A M Covey; D Fleischer; G I Getrajdman; W Jarnagin; C Sofocleous; L Blumgart; M D'Angelica
Journal:  Ann Surg Oncol       Date:  2010-04-01       Impact factor: 5.344

6.  Biliary drainage method and temporal trends in patients admitted with cholangitis: a national audit.

Authors:  Julia McNabb-Baltar; Quoc-Dien Trinh; Alan N Barkun
Journal:  Can J Gastroenterol       Date:  2013-09       Impact factor: 3.522

7.  British Society of Interventional Radiology: Biliary Drainage and Stenting Registry (BDSR).

Authors:  R Uberoi; N Das; J Moss; I Robertson
Journal:  Cardiovasc Intervent Radiol       Date:  2011-02-08       Impact factor: 2.740

8.  Percutaneous transhepatic biliary drainage in patients with advanced solid malignancies: prognostic factors and clinical outcomes.

Authors:  Marcela Crosara Teixeira; Milena Perez Mak; Daniel Fernandes Marques; Fernanda Capareli; Francisco Cesar Carnevale; Airton Mota Moreira; Ulysses Ribeiro; Ivan Cecconello; Paulo M Hoff
Journal:  J Gastrointest Cancer       Date:  2013-12

9.  Palliative treatment with self-expandable metallic stents in patients with advanced type III or IV hilar cholangiocarcinoma: a percutaneous versus endoscopic approach.

Authors:  Woo Hyun Paik; Young Soo Park; Jin-Hyeok Hwang; Sang Hyub Lee; Chang Jin Yoon; Sung-Gwon Kang; Jae Kyung Lee; Ji Kon Ryu; Yong-Tae Kim; Yong Bum Yoon
Journal:  Gastrointest Endosc       Date:  2008-07-26       Impact factor: 9.427

10.  Percutaneous self-expandable uncovered metallic stents in malignant biliary obstruction. Complications, follow-up and reintervention in 154 patients.

Authors:  M Inal; E Akgül; E Aksungur; H Demiryürek; O Yağmur
Journal:  Acta Radiol       Date:  2003-03       Impact factor: 1.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.